Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality
Authors
Keywords
Covid-19, Systematic review, Risk of bias, Meta-epidemiology, Methodological quality, Clinical trials, Randomized controlled trials
Journal
JOURNAL OF CLINICAL EPIDEMIOLOGY
Volume 139, Issue -, Pages 68-79
Publisher
Elsevier BV
Online
2021-07-15
DOI
10.1016/j.jclinepi.2021.07.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine
- (2020) Paul Elias Alexander et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Ramipril in High Risk Patients with COVID-19
- (2020) Ignacio J. Amat-Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
- (2020) Effat Davoudi-Monfared et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Waste in COVID-19 clinical trials conducted in western Europe
- (2020) Rafael Dal-Ré et al. European Journal of Internal Medicine
- Febuxostat therapy in outpatients with suspected COVID‐19: A clinical trial
- (2020) Lotfollah Davoodi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial
- (2020) Fang Zheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)
- (2020) Rui-fang Zhu et al. Journal of Translational Medicine
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
- (2020) Hemalkumar B Mehta et al. BMJ Open
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study
- (2020) Zhigang Ren et al. Advanced Science
- A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial
- (2020) Ke Hu et al. VIROLOGICA SINICA
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
- (2020) Spyridon G. Deftereos et al. JAMA Network Open
- Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
- (2020) Sherief Abd-Elsalam et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
- (2020) Yohei Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
- (2020) Naser Gharebaghi et al. BMC INFECTIOUS DISEASES
- Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study
- (2020) Ting Li et al. CTS-Clinical and Translational Science
- Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
- (2020) Maryam Edalatifard et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
- (2020) Ehsan Sekhavati et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
- (2020) Anahita Sadeghi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
- (2020) Hamideh Abbaspour Kasgari et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
- (2020) Marta Entrenas Castillo et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2020) Peter W Horby et al. LANCET
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
- (2020) Remo H M Furtado et al. LANCET
- An evaluation of the quality and impact of the global research response to the COVID ‐19 pandemic
- (2020) Mahesh Ramanan et al. MEDICAL JOURNAL OF AUSTRALIA
- Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
- (2020) Lei Shu et al. Stem Cell Research & Therapy
- Interim analysis of an open‐label randomized controlled trial evaluating nasal irrigations in non‐hospitalized patients with coronavirus disease 2019
- (2020) Kyle S. Kimura et al. International Forum of Allergy & Rhinology
- Treating Covid-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind, Randomized Controlled Trial in Hospitalized Patients
- (2020) Robert J Ulrich et al. Open Forum Infectious Diseases
- Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial
- (2020) Xiaoke Wu et al. Engineering
- Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
- (2020) Khalil Ansarin et al. BioImpacts
- Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
- (2020) Anna Cristina Bertoldi Lemos et al. THROMBOSIS RESEARCH
- Machine learning for identifying Randomized Controlled Trials: An evaluation and practitioner's guide
- (2018) Iain J. Marshall et al. Research Synthesis Methods
- Industry-funded versus non-profit-funded critical care research: a meta-epidemiological overview
- (2018) Perrine Janiaud et al. INTENSIVE CARE MEDICINE
- The association of funding source on effect size in randomized controlled trials: 2013–2015 – a cross-sectional survey and meta-analysis
- (2017) Alberto Falk Delgado et al. Trials
- Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
- (2014) J Savović et al. HEALTH TECHNOLOGY ASSESSMENT
- Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis
- (2012) Nasim A. Khan et al. ARTHRITIS AND RHEUMATISM
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
- (2008) Lesley Wood et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started